Clinical trial
clinical trial
Tamoxifen citrate, letrozole, anastrozole, or exemestane with or without chemotherapy in treating patients with invasive RxPONDER breast cancer
Intervention
Drug intervention
Intervention Type
drug intervention
has_intervention
Anastrozole
drug intervention
Anastrozole
Intervention
intervention
planned process
planned process
process
occurrent
entity
Drug intervention
drug intervention
Exemestane
drug intervention
Exemestane
Intervention
intervention
planned process
planned process
process
occurrent
entity
Drug intervention
drug intervention
Systemic chemotherapy
drug intervention
Systemic chemotherapy
Intervention
intervention
planned process
planned process
process
occurrent
entity
Drug intervention
drug intervention
Tamoxifen citrate
drug intervention
Tamoxifen citrate
Intervention
intervention
planned process
planned process
process
occurrent
entity
Drug intervention
drug intervention
Letrozole
drug intervention
Letrozole
Intervention
intervention
planned process
planned process
process
occurrent
entity
Contact
has contact
has_contact
Berenberg, Jeffrey
PI
has PI
has_PI
Topic
has topic
has_topic
breast cancer
Funded by
funded by
funded_by
SWOG
Phase
Phase 3 clinical trial
has phase
has_phase
Phase 3
Performed by
human study performed by
human_study_performed_by
Clinical Protocol & Data Management Shared Resource
http://www.clinicaltrials.gov/ct2/show/NCT01272037?term=S1007&rank=1
ClinicalTrials.gov url
ClinicalTrials.gov url
CTurl
http://www.cancer.gov/clinicaltrials/search/view?cdrid=692475&version=healthprofessional
Website(s)
has URL
has_url
This phase III clinical trial is studying how well giving tamoxifen citrate, anastrozole, letrozole, or exemestane with or without chemotherapy works in treating patients with invasive breast cancer.
Resource Description
resource_description
Phase III, randomized clinical trial of standard adjuvant endocrine therapy +/- chemotherapy in patients with 1-3 positive nodes, hormone receptor-positive and HER2-negative breast cancer with recurrence score (RS) of 25 or less
Additional Name
eagle-i_synonym
Females age 18 and older with histologically confirmed invasive breast cancer meeting criteria detailed on ClinicalTrials.gov.
Study Population
study population
has_study_population
2011-06-29T19:23:04.974-05:00
awendicke (Annemarie Wendicke)
2011-09-23T11:30:18.136-05:00
workflow state
Published
mwilson (Melanie Wilson)
nvasilevsky
Interventional study
Research project
research project
Human Study
human study
human study
planned process
planned process
Quantitative human study
process
occurrent
entity